Education
About Us
Working with TipRanks
Follow Us
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607)
:2607
Earnings Data
Report Date
Mar 31, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.23Last Year’s EPS
0.15Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
Shanghai Pharmaceuticals Holding Co (HK:2607) Earnings, Revenues Date & History
HK:2607 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:2607 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | HK$12.11 | HK$12.20 | +0.73% |
Aug 28, 2025 | HK$12.28 | HK$12.18 | -0.81% |
Apr 28, 2025 | HK$10.38 | HK$10.27 | -1.11% |
Mar 27, 2025 | HK$11.02 | HK$11.23 | +1.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607) report earnings?
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607) is schdueled to report earning on Mar 31, 2026, TBA (Confirmed).
What is Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607) earnings time?
Shanghai Pharmaceuticals Holding Co Ltd Class H (HK:2607) earnings time is at Mar 31, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Shanghai Pharmaceuticals Holding Co Ltd Class H stock?
The P/E ratio of Shanghai Pharmaceuticals Holding Co is N/A.
What is HK:2607 EPS forecast?
HK:2607 EPS forecast for the fiscal quarter 2025 (Q4) is 0.23.